TCW Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.25M Buy
736,797
+192,100
+35% +$1.28M 0.04% 187
2026
Q1
$2.97M Buy
544,697
+97,900
+22% +$549K 0.02% 235
2025
Q4
$3.13M Hold
446,797
0.02% 232
2025
Q3
$3.45M Buy
446,797
+6,300
+1% +$49.2K 0.03% 166
2025
Q2
$3.84M Buy
440,497
+21,800
+5% +$158K 0.03% 202
2025
Q1
$3.33M Hold
418,697
0.03% 209
2024
Q4
$3.81M Buy
418,697
+150,317
+56% +$1.45M 0.03% 206
2024
Q3
$2.46M Buy
+268,380
New +$2.22M 0.02% 241

Other funds holding TDOC

TCW Group's TDOC Position: Q2 2026 in Review

TCW Group increased its Teladoc Health (TDOC) stake by 35% in Q2 2026, buying an estimated $1.28M and bringing the position to 736,797 shares worth $6.25M. The position accounts for 0.04% of the portfolio, ranked #187.

TCW Group first reported a position in TDOC in Q3 2024 and has held it in 8 quarters since. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • TCW Group held 736,797 shares of Teladoc Health worth $6.25M as of Q2 2026.
  • TCW Group bought 192,100 Teladoc Health shares in Q2 2026, an estimated $1.28M.
  • Teladoc Health made up 0.04% of TCW Group's portfolio in Q2 2026, its #187 holding.
  • TCW Group first reported a position in Teladoc Health in Q3 2024 and has held it in 8 quarters since.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.